EnableInsights
Get in touch

Find a Tender · Contract

Proprietary Drugs

A public procurement published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts) via Find a Tender.

Find a TenderContract
—
Award value
£392.8m
Tender value
72
Suppliers
72
Awards
2
Notices
Contract
Stage

Overview

Procurement for the provision of branded drugs.

Key details

Buyer
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
Source
Find a Tender
Lifecycle stage
Contract
Status
active
CPV classification
33600000 — Pharmaceutical products
Currency
GBP
Total award value
—
Tender value
£392,774,896
First published
15 Oct 2024
Last updated
28 Jul 2025
View the original notice

Awards

72 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Abbvie Limited08004972—active—
Accord UK Limited00079585—active—
Alliance Pharmaceuticals Limited03250064—active—
Amarox10997632—active—
Amicus Therapeutics UK Operations Ltd12148755—active—
AMO United Kingdom Ltd04359842—active—
Aspen Pharmacare UK Limited11411661—active—
Aspire Pharma Ltd06828501—active—
Astellas Pharma Ltd00787610—active—
Astra Zenica——active—
Baxter Healthcare Limited00461365—active—
Bayer Plc——active—
Biogen Idec Limited01497267—active—
Camurus AB——active—
Chiesi Limited02140985—active—
Chugai Pharma UK Ltd——active—
Cipla EU Limited04513292—active—
Colonis Pharma Ltd05486832—active—
CST Pharma——active—
Dr Falk Pharma UK Ltd02307698—active—
Dr Reddy's Laboratories (UK) Ltd01729064—active—
Eisai Limited02242511—active—
Eli Lilly & Company Ltd00284385—active—
Essential Pharma07514667—active—
Esteve Pharmaceuticals03393686—active—
Ferring Pharmaceuticals Ltd01198007—active—
Flynn Pharma LtdFC018156—active—
Focus Pharmaceuticals Ltd04522142—active—
Galen LimitedNI056542—active—
Gedeon Richter——active—
Glaxo Smithkline——active—
Glenmark Pharmaceuticals——active—
IBSA Pharma Ltd03929804—active—
Ipsen Limited06751069—active—
Janssen Limited——active—
Juvise Pharmaceuticals——active—
Kent Pharmaceuticals03371228—active—
Kyowa Kirin International UK Newco LtdSC742341—active—
Lupin Healthcare (UK) Limited06925119—active—
Luye Pharma Ltd11567378—active—
Martindale——active—
Mercury Pharmaceuticals Ltd02619880—active—
Merz Pharma UK Ltd04703428—active—
Morningside Pharmaceuticals Limited02672877—active—
Napp Pharmaceutical Group Ltd00884285—active—
Neon Healthcare Ltd06844351—active—
Novartis Pharmaceuticals UK Limited00119006—active—
Novo Nordisk Pharmaceuticals Ltd——active—
Organon Pharma (UK) Limited00820771—active—
Orion Pharma UK Ltd02281057—active—

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeProprietary Drugs
  2. Award,contractProprietary Drugs

All suppliers

Frameworks & programmes

More from Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)

Biologic and Biosimilar Medicines
Contract · Find a Tender

FAQs about this procurement

Who is the buyer for "Proprietary Drugs"?

Proprietary Drugs is a UK public-sector procurement published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts) via Find a Tender.

Has "Proprietary Drugs" been awarded?

Yes — 72 awards are recorded, with a reported total value of £392,774,896. The current lifecycle stage is "Contract".

Which suppliers are involved in "Proprietary Drugs"?

72 suppliers are linked: Abbvie Limited, Accord UK Limited, Alliance Pharmaceuticals Limited, Amarox, Amicus Therapeutics UK Operations Ltd, AMO United Kingdom Ltd, Aspen Pharmacare UK Limited, Aspire Pharma Ltd.

What is "Proprietary Drugs" worth?

The reported tender value is £392,774,896.

When was "Proprietary Drugs" published?

It was first published on 15 Oct 2024 and last updated on 28 Jul 2025, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable